These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6438839)

  • 1. Cryoprecipitated antihemophilic factor production from blood collected in quad packs or from blood with delayed processing. The importance of plasma thawing method.
    Orthner CL; MacPherson JL
    Transfusion; 1984; 24(6):516-9. PubMed ID: 6438839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of cryoprecipitated factor VIII concentrates.
    Slichter SJ; Counts RB; Henderson R; Harker LA
    Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Storage of thawed cryoprecipitated AHF is better at room temperature than at 1 degree C to 6 degrees C for factor VIII content.
    Saxena S; Odono V; Francis R; Shulman IA
    Arch Pathol Lab Med; 1991 Apr; 115(4):343-5. PubMed ID: 1901483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postfiltration factor VIII and fibrinogen levels in cryoprecipitate stored at room temperature and at 1 to 6 degrees C.
    Spivey MA; Jeter EK; Lazarchick J; Kizer J; Spivey LB
    Transfusion; 1992 May; 32(4):340-3. PubMed ID: 1585439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
    Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
    Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of labile coagulation factors and fibrinogen in thawed plasma during a 5 day storage period in the hospital blood bank refrigerator.
    Bahreini S; Javadzadeh Shahshahani H; Nasizadeh S; Ahmadinejad M
    Transfus Med; 2021 Dec; 31(6):494-498. PubMed ID: 34605106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.
    Vermeer C; Soute BA; Ates G; Brummelhuis HG
    Vox Sang; 1976; 30(1):1-22. PubMed ID: 1251567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of large-scale fractionation methods. VI. An improved method for preparation of antihemophilic factor.
    Wickerhauser M; Mercer JE; Eckenrode JW
    Vox Sang; 1978; 35(1-2):18-31. PubMed ID: 664566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
    Wensley RT; Snape TJ
    Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.
    Farrugia A; Prowse C
    J Clin Pathol; 1985 Apr; 38(4):433-7. PubMed ID: 3921572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave-thawed plasma for cryoprecipitate production.
    Bass H; Trenchard PM; Mustow MJ
    Vox Sang; 1985; 48(2):65-71. PubMed ID: 3934842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
    Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
    Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of factor VIII recovery in cryoprecipitate.
    Kasper CK; Myhre BA; McDonald JD; Nakasako Y; Feinstein DI
    Transfusion; 1975; 15(4):312-22. PubMed ID: 1166504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of antihemophilic factor from indated plasma.
    Wickerhauser M
    Transfusion; 1976; 16(4):345-50. PubMed ID: 951729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of prolonged storage on coagulation Factor (F)V, FVII, and FVIII in thawed plasma: is it time to extend the expiration date beyond 5 days?
    Tholpady A; Monson J; Radovancevic R; Klein K; Bracey A
    Transfusion; 2013 Mar; 53(3):645-50. PubMed ID: 22803679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in cryoprecipitate production.
    Rock G; Tittley P
    Transfusion; 1977; 17(1):50-3. PubMed ID: 841673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yields of fibronectin by heparin-cold-precipitation from plasma.
    Tien SL; Ong YW; Lim SH; Chiang T
    Ann Acad Med Singap; 1990 Nov; 19(6):831-2. PubMed ID: 2130748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of factor VIII and von Willebrand factor activities during cold storage of whole blood is reversed by rewarming.
    Refaai MA; Van Cott EM; Lukoszyk M; Hughes J; Eby CS
    Lab Hematol; 2006; 12(2):99-102. PubMed ID: 16751138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid thawing of fresh-frozen plasma with radio wave-based thawing technology and effects on coagulation factors during prolonged storage at 4 degrees C.
    Boström F; Ekemar L; Olsson D; Egberg N; Lundahl J
    Vox Sang; 2009 Jul; 97(1):34-8. PubMed ID: 19490580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing factor VIII activity in frozen plasma.
    Swärd-Nilsson AM; Persson PO; Johnson U; Lethagen S
    Vox Sang; 2006 Jan; 90(1):33-9. PubMed ID: 16359353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.